FUL Earnings

FUL reported its earnings on 2026-03-25, showcasing a revenue of 770.84M against an estimate of 790.10M, resulting in a -2.44% surprise. The EPS was 0.57, surpassing the expected 0.56 by 1.79%. The stock experienced a 0.49% price change on the earnings day and a 8.76% change over the next five days, reflecting market reactions to the results.

Following FUL's earnings announcement on 2026-03-25, the stock price moved by 0.49% on the day of the release. Over the subsequent five days, it saw a 8.76% change. Historically, FUL's stock price tends to shift by an average of 0.48% in the 10 days leading up to earnings and 0.53% in the 10 days following, providing insight into potential market.

For 2026/Q2, analysts estimate FUL's annual revenue to reach 915.41M, while the EPS is projected at 1.30. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between FUL's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, FUL's stock price typically moves by 0.48% in the 10 days before its earnings and 0.53% in the 10 days after. For the upcoming 2026/Q2 earnings, analysts expect an EPS of 1.30 and revenue of 915.41M.

The earnings call presents a mixed outlook. While there are positive elements such as strong performance in medical-grade adhesives and strategic pricing actions, challenges persist with volume declines, inflationary pressures, and raw material supply issues. The company's guidance suggests modest revenue growth, but flat organic growth and a cautious economic environment indicate limited upside. The Q&A reveals concerns about raw material costs and geopolitical impacts, which temper optimism. Given the market cap, the stock is likely to experience a neutral reaction, with a price movement between -2% to 2%.